Education š
Dr. Wei Nana completed her Ph.D. in Preventive Veterinary Medicine in 2018 through a joint program at South China Agricultural University and the Shanghai Veterinary Research Institute. She also holds a Masterās degree in the same field (2012) and a Bachelor’s degree in Agriculture from Liaocheng University (2009). Her research has consistently focused on addressing critical issues in molecular and animal medicine, from oncolytic virus development to immune modulation.
Experience š¼
Dr. Wei’s career spans academia, research, and biotechnology. At East China Normal University, she currently explores gut microbiotaās role in neurological disorders and develops organoid platforms. Previously, she held postdoctoral positions at the Shanghai Veterinary Research Institute, where her work on gut flora in diabetes and cancer earned recognition. Dr. Wei also has experience in the biotechnology sector, managing biomedical projects and leading teams in Shanghai-based companies.
Research Interests š¬
Dr. Wei Nana is passionate about interdisciplinary research. Her interests include the interactions between gut microbiota and systemic diseases, organoid applications, and molecular mechanisms of pathogen-host dynamics. She is particularly committed to leveraging her expertise to improve cancer treatment strategies and advance the understanding of mental illness.
Awards š
Dr. Wei has received numerous accolades for her achievements, including:
Shanghai Young Science and Technology Talent Sailing Program Award,
Outstanding Talents of Minhang Chunshen Talent Pyramid Program,
Advanced and Civilized Staff of the Shanghai Veterinary Research Institute.
Several academic paper awards, including first and second prizes at conferences.
Publications š
Dr. Wei Nana has authored numerous impactful articles in high-impact journals. Notable publications include:
“Transplantation of gut microbiota derived from patients with schizophrenia induces schizophrenia-like behaviors and dysregulated brain transcript response in mice”
“Characterization of oral bacterial and fungal microbiome in recovered COVID-19 patients”
“Profiles of Microbial Community and Antibiotic Resistome in Wild Tick Species”
“Exosomes Derived From Dendritic Cells Infected With Toxoplasma gondii Show Antitumoral Activity in a Mouse Model of Colorectal Cancer”
“Systemic Evaluation of the Effect of Diabetes Mellitus on Breast Cancer in a Mouse Model”
“Systematic profiling of antigen bias in humoral response against SARS-CoV-2”
“Characterization of a single-domain von Willebrand factor type C protein (HaSVC) from the salivary gland of the tick Hyalomma asiaticum“
“Corrigendum: The Tick Microbiota Dysbiosis Promote Tick-Borne Pathogen Transstadial Transmission in a Babesia microti Infected Mouse Model”
“The Tick Microbiota Dysbiosis Promote Tick-Borne Pathogen Transstadial Transmission in a Babesia microtiāInfected Mouse Model”
“Evaluation of enzymatic activity of Babesia microti thioredoxin reductase (Bmi TrxR)-mutants and screening of its potential inhibitors”
Conclusion š
Dr. Wei Nana embodies the qualities of an outstanding researcher, with a proven record of academic excellence, impactful publications, and leadership in her field. Her innovative work, particularly in the interplay between gut microbiota and systemic diseases, positions her as a frontrunner for the Research for Best Researcher Award. Addressing areas such as international collaborations and public outreach could further elevate her already impressive profile. Dr. Weiās dedication, expertise, and leadership make her a deserving candidate for this prestigious recognition.